https://www.avient.com/sites/default/files/2022-04/Edgetek PKE Processing Guide.pdf
BARREL TEMPERATURES ENGLISH (°F) METRIC (°C) COMMENTS Zone 1 - Rear 420° F 460° F 216° C 238° C Long residence times are not advised.
Zone 2 - Center 430° F 470° F 221° C 243° C Zone 3 - Front 440° F 480° F 227° C 249° C Nozzle 450° F 480° F 232° C 249° C MELT & MOLD TEMPERATURES ENGLISH (°F) METRIC (°C) COMMENTS Melt Temperature 450° F 480° F 232° C 249° C After processing, always purge residual PKE materials with fractional melt flow HDPE or PP.Mold Temperature 150° F 200° F 66° C 93° C DRYING CONDITIONS ENGLISH (°F) METRIC (°C) COMMENTS Temperature 180° F 82° C Drying not required.
https://www.avient.com/sites/default/files/2024-12/AVNT Investor Day 2024 Presentation.pdf
All Rights Reserved 2024 Avient is evolving to its next phase as an innovator of materials solutions to help our customers succeed, while enabling a sustainable world Key messages Our primary focus is on organic revenue growth and margin expansion ► intersect secular trends and high growth markets with our technologies ► catalyze growth in our core build businesses in high growth markets ► hybridization Our strategy is enabled and driven by our focus on (a) portfolio prioritization, (b) amplifying innovation, (c) digital for operational excellence and growth, and (d) leadership, talent and culture for the Avient of the future Copyright © .
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-technical-bulletin-sept-2020.pdf
TECHNICAL BULLETIN VERSAFLEX™ PF Tack Layer for Surface Protective Films Properties Versaflex PF MD6727 Versaflex PF MD6741 Versaflex PF MD6649 Versaflex PF 9512 Versaflex PF MD6666 Versaflex PF MD6748 Versaflex PF MD6700 Features Low Tack Low Tack; Used for tailoring tack with MD6700 Low-Medium Tack Value Offering Medium Tack Low Gel/Residuals Low Tack Build High Tack Peel Strength Low Low-Medium Medium Medium-High Medium-High High High Applications Optical Films Home Appliances Plastics Construction/Bare Metals Finished Metals Steel/Painted Metals Bare Metals MFR @ 190°C/2.16 kg -- 4.5 17 5.4 21 4.8 6.5 MFR @ 230°C/2.16 kg 10 20 -- -- -- -- -- Specific Gravity, g/cc 0.92 0.91 0.92 0.92 0.94 0.94 0.94 Hardness, Shore A 50 49 37 38 37 31 30 G' @ 23°C, Pa 28.0 x 105 10.4 x 106 8.3 x 105 -- 9.9 x 105 11.8 x 105 10.0 x 105 DMA Tg, °C -29 -30 -9 10 11 15 21 LDPE/Versaflex PF Film1 180° Peel, N/25mm Stainless Steel after 20 min @ 25°C 0.5 2.2 3.2 6.1 6.7 8.5 8.6 after 7 days @ 25°C 0.6 2.7 4.3 5.5 8.2 8.3 10.3 PMMA2 after 20 min @ 25°C 1.1 1.7 3.8 4.9 6.9 8.3 8.8 after 20 min @ 75°C 2.8 4.1 5.1 6.9 9.0 10.7 11.8 after 7 days @ 75°C 4.0 4.4 5.9 9.8 8.4 9.8 10.3 Polycarbonate3 after 20 min @ 25°C 1.4 2.2 3.8 6.8 6.3 8.4 7.0 after 20 min @ 75°C 3.4 4.8 6.7 8.8 8.8 10.0 11.8 after 7 days @ 75°C 4.6 6.5 7.5 10.6 11.6 10.6 13.8 1 Film thickness: 51 micron LDPE/25 micron Versaflex PF 2 Arkema Plexiglas™ V052-100 (Plexiglas is a trademark of Arkema France Corp.) 3 Sabic Lexan™ L52-111 (Lexan is a trademark of Sabic Innovative Plastics) PHYSICAL PROPERTIES OF SELECTED VERSAFLEX PF TACK LAYER FORMULATIONS PRODUCT DESCRIPTION Versaflex™ PF formulations are specially developed for the manufacture of co-extruded surface protective films that apply easily, maintain tack with minimal build, peel smoothly and remove completely with little-to-no residue or ghosting.
TAILORING TACK BY BLENDING VERSAFLEX PF Film Thickness: 39 micron LDPE/13 micron Versaflex PF F = Final tack after 7 days @ 25° C i = Initial tack after 20 mins @ 25° C Pe el S tr en gt h on S te el , N /2 5m m Pe el S tr en gt h on S te el , N /2 5m m PEEL STRENGTH ON STAINLESS STEEL Film Thickness: 51 micron LDPE/25 micron Versaflex PF F F F F F F F i i i i i i i www.avient.com Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2021-04/versaflex-hc-3810-covid-19-containment-tube-screw-caps-case-study.pdf
DIAGNOSTICS MANUFACTURER C O V I D - 1 9 C O N T A I N M E N T T U B E S C R E W C A P S • Wide range of durometers with consistent raw materials • Processing consistencies across the durometer ranges for an easy transition between materials • Materials formulated without animal derivatives at a competitive cost • Offered a comprehensive range of solutions to accommodate specific application demands such as barrier, flexibility, and sealing performance • Provided materials manufactured in an ISO 13485 certified facility • Delivered a series of medical-grade TPEs that could be extruded and injection molded Versaflex™ HC 3810 Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
D is t. ) R P M P P G K W R F U L A V Y G C P IF F F M C H X L H U N E M N F O E E C L K R A S C L A S H C E G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of February 5, 2021 Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of February 5, 2021 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 A vi en t P P G K W R R P M F U L A V Y G C P IF F F M C U N V R H X L E M N B N R E C L C E A S H F O E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of February 5, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi en t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-04/trilliant-hc-continuous-glucose-monitor-case-study.pdf
HEALTHCARE DEVICE OEM C O N T I N U O U S G L U C O S E M O N I T O R • Specific color matching for brand alignment and recognition • Chemically resistant material to help product last longer • Single source for materials and color expertise • Provided a pre-colored solution that met rigorous application requirements to improve color consistency between products • Incorporated scratch & mar resistant additives for improved durability • Offered the ability to run small pilot lots • Met regulatory requirements for USP Class VI Trilliant™ HC Thermoplastics KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-04/Metallic Effect Sulfone case study.pdf
PTFE Wire insulation CONSUMER & AEROSPACE MOLDERS M E T A L L I C - E F F E C T S U L F O N E S O L U T I O N • Metallic appearance • FDA-food contact compliance* • Resistant to repeated washing, steam sterilization, and chemical disinfection cycles • Easy processing to meet flexible design requests • Lightweight to support a reduction in carbon emissions • Created a variety of food contact-approved, brilliant metallic effect colors such as gold, silver, and bronze for optimal aesthetics • Ensured excellent mechanical performance after repeated steam sterilization and harsh chemical cleaning cycles • Offered low MOQ with flexible supply options Colorant Chromatics and BASF Ultrason® high-performance polymers in metallic colors KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-04/trilliant-hc8900-medical-device-housing-case-study.pdf
DEVICE MANUFACTURER M E D I C A L D E V I C E H O U S I N G • Improved chemical resistance compared to PC/ABS, PC/PET & COPE • Flame retardant (FR) rating of V-1 at 0.75 mm • Zero BPA & non-halogenated FR material • Available in standard hospital grade pre-colors • Provided a cost-effective material with superior chemical resistance to traditional materials • Formulated a medical-grade, semi-crystalline blend to support regulatory testing and approvals • Demonstrated superior property retention and crack resistance after exposure to hospital- grade disinfectants, including Virex® Tb, helping to extend the device life Trilliant™ HC8900 Thermoplastics KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-04/versaflex-hc-bt218-biopharmaceutical-tubing-case-study.pdf
MEDICAL TUBING EXTRUDER B I O P H A R M A C E U T I C A L T U B I N G • Low leachables & extractables • Great tensile performance and kink resistance • Good thermal weldability • Excellent clarity and medical blue tint • ISO 10993-4 & 5, USP Class VI & Animal Derivative Free (ADF) • Supplied drop-in material replacement to overcome supply constraints of incumbent TPE • Offered a lower extractable profile than comparable materials in the market • Enabled easy material transition without changes in tooling or thermal welding machine settings • Formulated solution with proprietary additives to provide clarity and prevent yellowing after sterilization Versaflex™ HC BT218 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?